维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

6篇 您的检索式：作者名="Barbara Conti"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Shedding light on bioactivity of botanical by-products: neem cake compounds deter oviposition of the arbovirus vector Aedes albopictus (Diptera: Culicidae) in the field显示文摘	Giovanni Benelli Barbara Conti Rita Garreffa Marcello Nicoletti	2014	Parasitology Research2014，，3：	1
	2	Larvicidal and ovideterrent properties of neem oil and fractions against the filariasis vector Aedes albopictus (Diptera: Culicidae): a bioactivity survey across production sites显示文摘	Giovanni Benelli Stefano Bedini Francesca Cosci Chiara Toniolo Barbara Conti Marcello Nicoletti	2015	Parasitology Research2015，，1：	1
	3	Old ingredients for a new recipe? Neem cake, a low-cost botanical by-product in the fight against mosquito-borne diseases显示文摘	Giovanni Benelli Kadarkarai Murugan Chellasamy Panneerselvam Pari Madhiyazhagan Barbara Conti Marcello Nicoletti	2015	Parasitology Research2015，，2：	1
	4	Essential oil composition and larvicidal activity of six Mediterranean aromatic plants against the mosquito Aedes albopictus (Diptera: Culicidae)显示文摘	Barbara Conti Angelo Canale Alessandra Bertoli Francesca Gozzini Luisa Pistelli	2010	Parasitology Research2010，，6：	1
	5	Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients显示文摘	Vicini Chilovi Barbara Conti Marta Zanetti Marina Mazzù Ilenia Rozzini Luca Padovani Alessandro	2009	Dementia and Geriatric Cognitive Disorders2009，，4：	1
	6	Optimization of the pharmacological therapy in patients with polyvascular disease: A multidisciplinary approach显示文摘The recent shift of the concept of cardiovascular disease as a chronic progressive condition,potentially involving multiple districts,has driven attention to the optimal management of patients with concomitant coronary and peripheral artery disease,representing a subset of patients with an increased risk of events and impaired survival.Recent pharmacological achievements in terms of antithrombotic therapy and lipid-lowering drugs allow multiple therapeutical combinations,thus requiring optimizing the treatment in a tailored fashion according to patients’risk profiles.Nevertheless,data dedicated to this specific subset of patients are still modest.We summarize currently available strategies and indications for the management of antithrombotic and lipid-lowering drugs in patients with the poly-vascular disease.	Rocco Gioscia Claudio Castagno Monica Verdoia Barbara Conti Enzo Forliti Andrea Rognoni	2023	World Journal of Cardiology2023，15，4：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费